Main Article Content
There has been remarkable progress in the study of the causes, the pathogenesis,
and the mechanism of cell death in neurodeneurodegenerative diseases such as
Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and
polyglutamine diseases. Several new therapeutic approches, which are more closely
targeted to the pathogenesis of the disease, are being explored. This review
summerizes the development of these potentially disease modifying treatments.
Upon acceptance of an article, the Pharmacological and Therapeutic Society of Thailand will have exclusive right to publish and distribute the article in all forms and media and grant rights to others. Authors have rights to use and share their own published articles.